Prognostic Factors for Toxicity and Survival in Advanced Cervical Cancer Patients Treated With High-Dose-Rate (HDR)-Intracavitary Brachytherapy (ICBT) Combined With Complementary Intensity Modulated Radiation Therapy (IMRT)
第一作者机构：[1]Si Chuan Cancer Hospital, Chengdu, China,
推荐引用方式(GB/T 7714)：
Mei F.,Lang J.,Li Z.,et al.Prognostic Factors for Toxicity and Survival in Advanced Cervical Cancer Patients Treated With High-Dose-Rate (HDR)-Intracavitary Brachytherapy (ICBT) Combined With Complementary Intensity Modulated Radiation Therapy (IMRT)[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2014,90:S487-S487.doi:10.1016/j.ijrobp.2014.05.1505.
APA：
Mei, F.,Lang, J.,Li, Z.,Yin, G.,Tan, Y....&Wang, P..(2014).Prognostic Factors for Toxicity and Survival in Advanced Cervical Cancer Patients Treated With High-Dose-Rate (HDR)-Intracavitary Brachytherapy (ICBT) Combined With Complementary Intensity Modulated Radiation Therapy (IMRT).INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,90,
MLA：
Mei, F.,et al."Prognostic Factors for Toxicity and Survival in Advanced Cervical Cancer Patients Treated With High-Dose-Rate (HDR)-Intracavitary Brachytherapy (ICBT) Combined With Complementary Intensity Modulated Radiation Therapy (IMRT)".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 90.(2014):S487-S487
医学